• Mashup Score: 2

    Learn how the new SCAI guidance regarding PCI within non-surgical facilities broadens the use of plaque modification devices all U.S. cath labs. We’ll dig into intravascular lithotripsy’s (IVL) mechanism of action and how lithotripsy bridges the gap between a safe and effective calcium modification technology for use in facilities lacking on site surgical backup.

    Tweet Tweets with this article
    • Link to webinar on SCAI guidance for PCI in no SOS centers & #IVL Rx for calcified lesions (including info about reimbursement) —> https://t.co/vI0EFOFo7P #ACCEarlyCareer #ACCFIT #ACCIC #CardioTwitter #ACCWIC @scaiwin @SCAI @WomenAs1 @agtruesdell #IVL @CvUnmc @UNMC_IM #UNMCIm https://t.co/G2cjxa0igu

  • Mashup Score: 0

    January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced it has entered into a definitive agreement to acquire Neovasc Inc., a company focused on the minimally invasive treatment of refractory angina.  The Neovasc Reducer System is a first-of-its-kind technology to address…

    Tweet Tweets with this article
    • @DAICeditor @ShockwaveIVL @Neovasc #Shockwave, a pioneer in the development of #IVL, announced it has entered into a definitive agreement to #acquire #Neovasc Inc., a company focused on the minimally invasive treatment of #refractory #angina: https://t.co/tnr5fgMHji